Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

The clinical spectrum of pulmonary aspergillosis

Open access

Abstract

The clinical presentation of Aspergillus lung disease is determined by the interaction between fungus and host. Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant recipients, the critically ill patients and patients on steroids. A high index of suspicion is required in patients without the classical risk factors as early presentation is usually silent and non-specific, pyrexia uncommon and timely treatment is crucial for survival. Invasive aspergillosis has also been diagnosed in normal hosts after massive exposure to fungal spores. Chronic pulmonary aspergillosis affects patients without obvious immune compromise, but with an underlying lung condition such as COPD or sarcoidosis, prior or concurrent TB or non-tuberculous mycobacterial disease. Aspergillus bronchitis may be responsible for persistent respiratory symptoms in patients with Aspergillus detected repeatedly in sputum without evidence of parenchymal Aspergillus disease, especially in patients with bronchiectasis and cystic fibrosis. Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. Changes in the classification of Aspergillus allergic lung disease have been proposed recently. Cases of extrinsic allergic alveolitis and chronic pulmonary aspergillosis have been observed after Aspergillus exposure. Asymptomatic colonisation of the respiratory tract needs close monitoring as it can lead to clinical disease especially with ongoing immunosuppression. The various syndromes should be viewed as a semicontinuous spectrum of disease and one form may evolve into another depending on the degree of ongoing immunosuppression.

Overview

Integrity signals

Registry

Crossref · 10.1136/thoraxjnl-2014-206291

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 71 references

Cited by

See all 850

Metadata

Authors
Kosmidis, C., & Denning, D. W.
Affiliations
Manchester Academic Health Science Centre (GB)
Corresponding author
Kosmidis, C.
Venue
Thorax
Publisher
BMJ
Published
2014-10-29
Volume
70
Issue
3
Pages
270-277
ISSN
0040-6376 (ISSN-L)
OpenAlex
W2143691385
Cited by
850
References
71
Citations by year
2026: 53 · 2025: 80 · 2024: 72 · 2023: 87 · 2022: 96 · 2021: 109 · 2020: 99 · 2019: 64 · 2018: 61 · 2017: 50 · 2016: 44 · 2015: 31
FWCI
5.80
Type
journal article
Language
en
Open access
Locations
  • Thorax (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
pulmonary aspergillosis, invasive aspergillosis, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, hypersensitivity pneumonitis, immunosuppression, neutropenia, lung transplant recipients, cystic fibrosis, bronchiectasis, asthma, chronic obstructive pulmonary disease, sarcoidosis, nontuberculous mycobacterial infection, fungal colonization, disease spectrum
MeSH terms
Antifungal Agents, Aspergillosis, Allergic Bronchopulmonary, Asthma, Chronic Disease, Cystic Fibrosis, Humans, Neutropenia, Steroids, Tuberculosis, Pulmonary, Lung Transplantation, Critical Illness, Immunocompromised Host, Pulmonary Aspergillosis, Invasive Pulmonary Aspergillosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The clinical spectrum of pulmonary aspergillosis. https://app.cochat.ai/papers/10.1136/thoraxjnl-2014-206291
The paper
Kosmidis, C., & Denning, D. W. (2015). The clinical spectrum of pulmonary aspergillosis. Thorax. https://doi.org/10.1136/thoraxjnl-2014-206291

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.